Five-year survival of patients with metastatic renal cell carcinoma in the Russian Federation: results from the RENSUR5 registry

I Tsimafeyeu, T Zolotareva, S Varlamov, R Zukov… - Clinical genitourinary …, 2017 - Elsevier
Background The 5-year overall survival (OS) of patients with metastatic renal cell carcinoma
(mRCC) has been rarely reported. The aim of the RENSUR5 registry study was to obtain …
被引用次数：52 相关文章

Five-year Survival of Patients With Metastatic Renal Cell Carcinoma in the Russian Federation: Results From the RENSUR5 Registry

I Tsimafeyeu, T Zolotareva… - Clinical …, 2017 - pubmed.ncbi.nlm.nih.gov
Background The 5-year overall survival (OS) of patients with metastatic renal cell carcinoma
(mRCC) has been rarely reported. The aim of the RENSUR5 registry study was to obtain …

[引用][C] Five-year Survival of Patients With Metastatic Renal Cell Carcinoma in the Russian Federation: Results From the RENSUR5 Registry

I Tsimafeyeu, T Zolotareva, S Varlamov… - Clinical genitourinary …, 2017 - elibrary.ru

Five-year Survival of Patients With Metastatic Renal Cell Carcinoma in the Russian Federation: Results From the RENSUR5 Registry.

I Tsimafeyeu, T Zolotareva, S Varlamov… - Clinical Genitourinary …, 2017 - europepmc.org
Background The 5-year overall survival (OS) of patients with metastatic renal cell carcinoma
(mRCC) has been rarely reported. The aim of the RENSUR5 registry study was to obtain …

Five-year Survival of Patients With Metastatic Renal Cell Carcinoma in the Russian Federation: Results From the RENSUR5 Registry

I Tsimafeyeu, T Zolotareva… - Clinical …, 2017 - clinical-genitourinary-cancer.com
Background The 5-year overall survival (OS) of patients with metastatic renal cell carcinoma
(mRCC) has been rarely reported. The aim of the RENSUR5 registry study was to obtain …